Søk i kliniske studier for: HBV vaccine (Engerix-B, recombinant hepatitis B surface antigen, 20µg/mL/vial, GlaxoSmithKline, Belg
Totalt 9 resultater
-
Hui ZhuangGuangxi Center for Disease Control and PreventionFullførtImmun respons | Hepatitt B | SeroprevalensKina
-
Universidad de ValparaisoGlaxoSmithKline; Roche Pharma AG; Aclin LaboratoryFullført
-
GlaxoSmithKlineRegion of Wallonia; Public Private Partnership with Institute for Medical...Fullført
-
Merck Sharp & Dohme LLCFullført
-
Dynavax Technologies CorporationFullførtHepatitt BForente stater
-
Merck Sharp & Dohme LLCFullført
-
Tehran University of Medical SciencesFullført
-
French National Agency for Research on AIDS and...GlaxoSmithKlineAvsluttet
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjonerForente stater, Australia